Fulcrum Therapeutics | 10-Q:季度报表
Fulcrum Therapeutics | 8-K:重大事件
Fulcrum Therapeutics | 4:持股变动声明-高管 Tourangeau Greg
Fulcrum Therapeutics | EFFECT:其他
Fulcrum Therapeutics | ARS:年度报告
Fulcrum Therapeutics | DEF 14A:股东委托书决议
Fulcrum Therapeutics | DEFA14A:其他
Fulcrum Therapeutics | 4:持股变动声明-高管 Horn Patrick Taylor
Fulcrum Therapeutics | 3:首次持股声明-高管 Horn Patrick Taylor
Fulcrum Therapeutics | 4:持股变动声明-高管 Tourangeau Greg
Fulcrum Therapeutics | 144:拟议出售证券
Fulcrum Therapeutics | 4:持股变动声明-高管 Sapir Alex
Fulcrum Therapeutics | S-8:员工福利计划证券登记
Fulcrum Therapeutics | S-3:特定交易注册声明
Fulcrum Therapeutics | 10-K:年度报表
Fulcrum Therapeutics | 8-K:重大事件
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Third Rock Ventures IV, L.P.(3.8%),Third Rock Ventures GP IV, L.P.(3.8%)等
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(18.8%),Peter Kolchinsky(18.8%)等
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)
Fulcrum Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(8.9%),Aaron Cowen(8.9%)等
暂无数据